Skip to content

Percutaneous Dilatational Tracheostomy and Thyroid Isthmus Penetration

Percutaneous Dilatational Tracheostomy and Thyroid Isthmus Penetration

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05792098
Acronym
PETRIS
Enrollment
200
Registered
2023-03-30
Start date
2023-04-06
Completion date
2025-12-12
Last updated
2023-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheostomy Complication

Keywords

percutaneous dilatational tracheostomy, ultrasound, mechanical ventilation

Brief summary

A prospective randomized interventional study will be conducted in the Military University Hospital Prague at the department of Anesthesiology and Intensive care. The incidence of thyroid isthmus penetration will be evaluated during percutaneous dilatational tracheostomy in two groups (ultrasound-guided puncture vs. standard approach using only anatomical landmarks).

Detailed description

A prospective randomized interventional study will be conducted in the Military University Hospital Prague at the department of Anesthesiology and Intensive care. Patients indicated by the attending physician to percutaneous dilatational tracheostomy (PDTS) due to long-term need for mechanical ventilation will be randomly divided into two groups. The standard procedure group will undergo PDTS by the attending physician in the standard manner based on clinical examination and anatomical landmarks using bronchoscopic navigation. In the second group, the attending physician will additionally use ultrasound navigation during the procedure. After insertion of the guidewire, before dilation is performed, patients in both groups will be examined by ultrasound by an independent physician - the study investigator - who will verify the position of the guidewire and its relationship to the surrounding structures. In case of malposition of the guidewire (unacceptable lateral or craniocaudal), the penetration site will be adjusted and the PDTS completed.

Interventions

PROCEDUREpercutaneous dilatational tracheostomy (PDTS)

Tracheostomy made by percutaneous dilatational technique

DIAGNOSTIC_TESTUltrasound examination

Ultrasound verification of guidewire position

DIAGNOSTIC_TESTBronchoscopy

Bronchoscopic control of guidewire position

Sponsors

Military University Hospital, Prague
CollaboratorOTHER
Charles University, Czech Republic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 Years and older * long-term need for mechanical ventilation

Exclusion criteria

* not willing to participate

Design outcomes

Primary

MeasureTime frameDescription
The guidewire penetration through the thyroid isthmus.During procedureIncidence of guidewire penetration through the thyroid isthmus in standard and ultrasound navigated percutaneous dilatational tracheostomy.
Monitoring the incidence of early postoperative complications.Up to 10 daysThe incidence of bleeding from tracheostomy canal during hospitalization depending on guidewire position, defined as the need for any intervention to stop the bleeding. The incidence of tracheostomy canal infection during hospitalization depending on guidewire position, defined as the presence of any clinical signs of inflammation (swelling, redness, pain, secretion production, dehiscence).

Secondary

MeasureTime frameDescription
Using ultrasound examination as a tool for PDTS navigation in terms of correct puncture site.During procedureMonitoring the frequency of guidewire position changes based on ultrasound examination.

Other

MeasureTime frameDescription
Ultrasound-based contraindication rate of percutaneous dilatational tracheostomy.During procedureMonitoring the incidence of tracheostomy technique change from planned percutaneous dilatation to surgical approach based on ultrasound examination.

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026